IS:SEQUENT Sequent Scientific Limited

Sequent Scientific Limited operates as an integrated pharmaceutical company in India and internationally. It develops human active pharmaceutical ingredients (APIs) across various therapies areas, such as anti-malarial, anthelmintics, anti-infective, antiviral, CNS, and dermatology; and produces animal health APIs in the areas of anthelmintics, anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also provides contract research services comprising analytical and bioanalytical services to support API, pharmaceutical, personal care, and nutraceutical companies. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is based in Mumbai, India.

187.45 INR
As of 01/17/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  India
Country of incorporation:  India
IPO date:  03/10/2016
Stock exchange:    National Stock Exchange O
Exchange country:   India
Market cap:   47,612,723,200 INR
Current dividend yield:   0.31%
Sedol:      BD4CB76

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy